- Home
- CGEN vs RMMZ Comparison
CGEN vs RMMZ Comparison
Compare CGEN & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- RMMZ
- Stock Information
- Founded
- CGEN 1993
- RMMZ 2022
- Country
- CGEN Israel
- RMMZ United States
- Employees
- CGEN N/A
- RMMZ N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- RMMZ Investment Managers
- Sector
- CGEN Health Care
- RMMZ Finance
- Exchange
- CGEN Nasdaq
- RMMZ Nasdaq
- Market Cap
- CGEN 125.3M
- RMMZ 126.0M
- IPO Year
- CGEN 2000
- RMMZ N/A
- Fundamental
- Price
- CGEN $1.95
- RMMZ $15.00
- Analyst Decision
- CGEN
- RMMZ
- Analyst Count
- CGEN 0
- RMMZ 0
- Target Price
- CGEN N/A
- RMMZ N/A
- AVG Volume (30 Days)
- CGEN 560.3K
- RMMZ 25.6K
- Earning Date
- CGEN 11-11-2025
- RMMZ 01-01-0001
- Dividend Yield
- CGEN N/A
- RMMZ 7.33%
- EPS Growth
- CGEN N/A
- RMMZ N/A
- EPS
- CGEN N/A
- RMMZ 0.82
- Revenue
- CGEN $22,144,000.00
- RMMZ N/A
- Revenue This Year
- CGEN N/A
- RMMZ N/A
- Revenue Next Year
- CGEN $208.08
- RMMZ N/A
- P/E Ratio
- CGEN N/A
- RMMZ $19.41
- Revenue Growth
- CGEN N/A
- RMMZ N/A
- 52 Week Low
- CGEN $1.13
- RMMZ $12.92
- 52 Week High
- CGEN $2.66
- RMMZ $16.99
- Technical
- Relative Strength Index (RSI)
- CGEN 60.17
- RMMZ 56.42
- Support Level
- CGEN $1.30
- RMMZ $14.67
- Resistance Level
- CGEN $2.38
- RMMZ $15.13
- Average True Range (ATR)
- CGEN 0.17
- RMMZ 0.17
- MACD
- CGEN 0.04
- RMMZ -0.00
- Stochastic Oscillator
- CGEN 57.00
- RMMZ 68.75
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.